1995
DOI: 10.1016/s0140-6736(95)90756-4
|View full text |Cite
|
Sign up to set email alerts
|

Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
32
0
1

Year Published

1997
1997
2006
2006

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(36 citation statements)
references
References 16 publications
3
32
0
1
Order By: Relevance
“…Many studies have shown that the ACE I/D polymorphism in humans is not associated with restenosis after balloon angioplasty. 20,21,61 Moreover, two randomized trials (MERCATOR 62 and MARCATOR 63 ) have failed to demonstrate any beneficial effect of ACE inhibition on the occurrence of angiographic restenosis after balloon angioplasty. Nevertheless, experimental 64,65 and clinical 66 studies have suggested that the contribution of neointimal hyperplasia to restenosis after balloon angioplasty is relatively limited and that lumen renarrowing is in fact related primarily to vessel remodeling.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many studies have shown that the ACE I/D polymorphism in humans is not associated with restenosis after balloon angioplasty. 20,21,61 Moreover, two randomized trials (MERCATOR 62 and MARCATOR 63 ) have failed to demonstrate any beneficial effect of ACE inhibition on the occurrence of angiographic restenosis after balloon angioplasty. Nevertheless, experimental 64,65 and clinical 66 studies have suggested that the contribution of neointimal hyperplasia to restenosis after balloon angioplasty is relatively limited and that lumen renarrowing is in fact related primarily to vessel remodeling.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, cell and tissue ACE levels have also been shown to be modulated by ACE gene polymorphism in humans. 11,12 Since Cambien et al 13 first described a significant association between the I/D polymorphism and myocardial infarction, many studies have tried to examine the association of the ACE genotype, not only with ischemic heart disease 14 -17 but with a variety of conditions ranging from hypertension 18,19 to coronary artery restenosis, 14,20,21 cardiac hypertrophy, 16,22,23 pulmonary hypertension, 24 diabetes, 25 and nephropathy. 26 -28 The results of these studies are contradictory and stress the importance of experimental models for testing the impact of the ACE gene polymorphism and its associated modulation of ACE expression on the cardiovascular and renal responses to these pathological processes.…”
mentioning
confidence: 99%
“…36,37 On the other hand, restenosis following coronary angioplasty without stent, which appears to be primarily due to vessel remodelling, 38 was not associated with ACE genotype. [39][40][41] Percutaneous transluminal renal angioplasty (PTRA) has become the treatment of first choice for renal artery FMD. Therefore, current diagnosis and classification of FMD is based on the angiographic rather than histologic appearance.…”
Section: 21mentioning
confidence: 99%
“…In the absence of any known strong predictors for post-PTCA restenosis, we selected this disease entity as a test case for a more comprehensive approach, with regard to both breadth of genotyping and analytical algorithms. In a cohort of post-PTCA patients three times larger than the largest sample studied so far, 4 a panel of 94 polymorphic markers was tested from 62 'candidate' genes (representing, broadly, genes related to lipid and homocysteine metabolism, vascular tone regulation, cellmatrix adhesion and interaction, matrix integrity, inflammatory and immune responses, thrombosis/coagulation, cellular homeostasis/cytoprotection mechanisms, and cell cycle/apoptotic pathways; see Table 1). …”
Section: Introductionmentioning
confidence: 99%